BCR and breast cancer: In contrast, cells co-transduced with BCR-ABL and either NUP98-HOXA9, Bmi1 or Hes1 continued to grow for at least 11 days (Figure S3), demonstrating the utility of the assay system to facilitate identification of genes that may contribute to the development of BC.